HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alexander Dömling Selected Research

Hypertension (High Blood Pressure)

11/2018Application of Silver Nanoparticles in the Multicomponent Reaction Domain: A Combined Catalytic Reduction Methodology to Efficiently Access Potential Hypertension or Inflammation Inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alexander Dömling Research Topics

Disease

31Neoplasms (Cancer)
04/2024 - 01/2005
4Inflammation (Inflammations)
11/2022 - 11/2018
3Asthma (Bronchial Asthma)
11/2022 - 10/2015
3COVID-19
01/2022 - 12/2020
3Schistosomiasis (Bilharziasis)
04/2012 - 09/2010
2Adenocarcinoma
02/2024 - 12/2022
2Neurodegenerative Diseases (Neurodegenerative Disease)
11/2022 - 07/2020
2Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 04/2020
1Carcinoma (Carcinomatosis)
01/2024
1Premature Aging
11/2022
1Hypercholesterolemia
11/2022
1Immune System Diseases (Immune Disorders)
11/2022
1Autoimmune Diseases (Autoimmune Disease)
11/2022
1Rheumatoid Arthritis
11/2022
1Psoriasis (Pustulosis Palmaris et Plantaris)
11/2022
1Psoriatic Arthritis
11/2022
1Animal Disease Models
01/2022
1Neoplasm Metastasis (Metastasis)
03/2021
1Carcinogenesis
01/2021
1Infections
12/2020
1Pathologic Processes
07/2020
1Disease Progression
07/2020
1Atherosclerotic Plaque (Atheroma)
04/2020
1Osteosarcoma (Osteogenic Sarcoma)
01/2019
1Hypertension (High Blood Pressure)
11/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2015
1Melanoma (Melanoma, Malignant)
12/2015
1Human Influenza (Influenza)
11/2015
1Chronic Obstructive Pulmonary Disease (COPD)
10/2015
1Chronic Bronchitis
10/2015
1Lung Diseases (Lung Disease)
10/2015
1Leukemia
03/2014
1Merkel Cell Carcinoma
05/2012
1Neglected Diseases
04/2012

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
01/2024 - 01/2011
7Monoclonal AntibodiesIBA
11/2022 - 12/2015
7AntibodiesIBA
09/2022 - 02/2014
3spirooxindoleIBA
02/2024 - 12/2022
3benzimidazoleIBA
02/2024 - 12/2022
3Praziquantel (Biltricide)FDA Link
04/2012 - 09/2010
2Immune Checkpoint ProteinsIBA
04/2024 - 01/2017
2EnzymesIBA
01/2023 - 01/2018
2ProdrugsIBA
01/2023 - 01/2018
2Interleukin-17 (Interleukin 17)IBA
11/2022 - 09/2022
2Peptides (Polypeptides)IBA
01/2022 - 01/2018
2Fluorouracil (Carac)FDA LinkGeneric
12/2021 - 01/2021
2ArginaseIBA
01/2021 - 07/2020
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021 - 04/2020
2Peptide Hydrolases (Proteases)FDA Link
01/2021 - 12/2020
2Oncogene Proteins (Oncogene Protein)IBA
01/2017 - 05/2012
1Thalidomide (Thalomid)FDA Link
12/2023
1Adhesives (Glues)IBA
12/2023
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
12/2023
1Cyclin DIBA
12/2022
1CytokinesIBA
11/2022
13-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA
01/2021
1Oxidoreductases (Dehydrogenase)IBA
01/2021
1N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
12/2020
1Biomarkers (Surrogate Marker)IBA
07/2020
1Atorvastatin (Lipitor)FDA Link
04/2020
1LipidsIBA
04/2020
1CholesterolIBA
04/2020
1RNA-Binding Proteins (RNA-Binding Protein)IBA
04/2019
1indoleIBA
01/2019
1SilverIBA
11/2018
1Epoxide HydrolasesIBA
11/2018
1gamma-Glutamyl Hydrolase (Carboxypeptidase G2)IBA
01/2018
1glucarpidaseIBA
01/2018
1EpitopesIBA
01/2018
1Methotrexate (Mexate)FDA LinkGeneric
01/2018
1Tumor Suppressor Protein p53IBA
01/2017
1AminesIBA
11/2015
1Amantadine (Aman)FDA LinkGeneric
11/2015
1Lipoxygenase (Lipoxygenase-1)IBA
10/2015
1EstersIBA
03/2014
1ethyl 3- (2- ((tert- butylamino)- 1- (N- (4- chlorobenzyl)formamido)- 2- oxoethyl)- 6- chloro- 1H- indole- 2- carboxylateIBA
03/2014
1Carboxylic AcidsIBA
03/2014
1LigandsIBA
02/2014
1sepantroniumIBA
05/2012
1SurvivinIBA
05/2012
1Cytostatic AgentsIBA
05/2012
1Bortezomib (Velcade)FDA Link
05/2012
11,2,3,4-tetrahydroisoquinolineIBA
04/2012
1TubulinIBA
01/2005
1Cytotoxins (Cytolysins)IBA
01/2005

Therapy/Procedure

11Therapeutics
01/2023 - 01/2005
4Immunotherapy
04/2024 - 02/2014
1Drug Therapy (Chemotherapy)
01/2022
1Secondary Prevention
04/2020